Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.

Clinical trial NCT01024920 · COMPLETED

Trial details

NCT number: NCT01024920
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2009-12-16
Primary completion: 2011-11-08
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.